LG AI Research and D&D Pharmatech Partner on Oral Peptide Drug Discovery

LG AI Research has announced a collaboration with D&D Pharmatech to accelerate the development of next-generation oral peptide drugs. The partnership aims to combine LG's artificial intelligence capabilities with D&D Pharmatech's expertise in peptide therapeutics to discover and develop orally…

Collaboration Announced

LG AI Research has entered into a collaboration with D&D Pharmatech to advance the discovery of next-generation oral peptide drugs. The announcement was made on

The partnership brings together LG AI Research's artificial intelligence and machine learning expertise with D&D Pharmatech's specialized knowledge in peptide therapeutics. The goal is to accelerate the development of oral peptide drugs, which are considered a promising area in pharmaceutical research.

Focus on Oral Bioavailability

Oral peptide drugs have historically been challenging to develop because peptides are typically broken down in the digestive system before they can reach their target. The collaboration aims to overcome these barriers using AI-driven design and optimization.

D&D Pharmatech brings its platform for discovering and developing peptide-based therapeutics. LG AI Research contributes its advanced AI models for molecular design and prediction. Together, they hope to identify peptide candidates that can be administered orally rather than by injection.

Implications for Drug Development

The collaboration represents a significant step in applying artificial intelligence to the field of peptide drug discovery. If successful, the partnership could lead to new treatment options that are more convenient for patients through oral administration.

LG AI Research has been expanding its work in applying AI to scientific problems, including drug discovery. D&D Pharmatech is a biopharmaceutical company focused on developing peptide therapeutics for various diseases. The specific financial terms of the collaboration were not disclosed in the announcement.

Related reading: LG AI Research Develops AI for Oral Peptide Drug Discovery, Semaglutide Conference Presentation Highlights at ADA 86th Scientific Sessions, MHC Class I vs II Peptide Binding: T Cell Presentation Explained, Peptide Mass Calculator: Molecular Mass and Key Properties for Research.